Skip to main content
OpenTrials

Clinical trial condition

Urinary Bladder Neoplasms

Explore clinical trials studying Urinary Bladder Neoplasms. Study availability and eligibility vary by location and protocol.

67 public trials 15 recruiting studies
Refine in advanced search Browse all conditions

Urinary Bladder Neoplasms trial results

Completed

A Study of TAR-200 in Combination With Cetrelimab and Cetrelimab Alone in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder

NCT04919512

Conditions
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +8 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
  • UAMS Winthrop P. Rockefeller Cancer Institute Little Rock, Arkansas, United States
  • Arkansas Urology Little Rock, Arkansas, United States
View all 109 locations
View Trial Details
Completed

A Study of Erdafitinib Versus Investigator Choice of Intravesical Chemotherapy in Participants Who Received Bacillus Calmette-Guérin (BCG) and Recurred With High Risk Non-Muscle-Invasive Bladder Cancer (NMIBC)

NCT04172675

Conditions
Carcinoma, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +12 more
Locations
  • Urological Associates of Southern Arizona, P.C. Tucson, Arizona, United States
  • USC Institute of Urology Los Angeles, California, United States
  • The Urology Center of Colorado Denver, Colorado, United States
  • Urological Research Network Hialeah, Florida, United States
View all 150 locations
View Trial Details

Related conditions